首页> 外国专利> Asymmetric Synthesis of Rocaglamides via Enantioselective Photocycloaddition Mediated by Chiral Bronsted Acids

Asymmetric Synthesis of Rocaglamides via Enantioselective Photocycloaddition Mediated by Chiral Bronsted Acids

机译:手性布朗斯台德酸介导的对映选择性光环加成反应不对称合成罗卡格列胺

摘要

The present invention provides a new strategies for the synthesis of compounds of the rocaglamide family and related natural products. The synthetic approach generally involves photochemical generation of an oxidopyrylium species from a 3-hydroxychromone derivative followed by an enantioselective 1,3-dipolar cycloaddition of the oxidopyrylium species to a dipolarophile in the presence of a TADDOL derivative. This approach can be used for the formation of adducts containing an aglain core structure. Methods of the conversion of aglain core structures to aglain, rocaglamide and forbaglin ring systems are also provided. The present invention also relates to the use of rocaglamide/aglain/forbaglin derivatives for the manufacture of medicaments for use in the treatment of cancer or cancerous conditions, disorders associated with cellular hyperproliferation, or NF-κB-dependent conditions.
机译:本发明提供了合成罗格列酰胺家族化合物和相关天然产物的新策略。合成方法通常涉及从3-羟基色酮衍生物光化学生成氧化吡咯类物质,然后在TADDOL衍生物存在下,将氧化吡咯类物质对映选择性1,3-偶极环加成至偶极亲和体。该方法可用于形成包含琼脂糖蛋白核心结构的加合物。还提供了将琼脂素核心结构转化为琼脂素,罗格列酰胺和forbag​​lin环系统的方法。本发明还涉及罗格列酰胺/琼脂糖蛋白/福尔巴林衍生物在制备用于治疗癌症或癌性疾病,与细胞过度增殖相关的疾病或NF-κB依赖性疾病的药物中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号